- 期刊
Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study
延伸閱讀
- 林金潭（2013）。A comparison study of the association of risk to develop other comorbid diseases, medical resource use between angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker drugs for patients with hypertension〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-1507201311155800
- Cheng, C., & Daskalakis, C. (2015). Association of Adipokines with Insulin Resistance, Microvascular Dysfunction, and Endothelial Dysfunction in Healthy Young Adults. Mediators of Inflammation, 2015(), 1098-1106-300. https://doi.org/10.1155/2015/594039
- Gowri, V., Rizvi, G., & Saquib, S. (2013). Relationship of High Sensitivity C-Reactive Protein and Other Biochemical Parameters of Metabolic Syndrome in Women with Polycystic Ovarian Syndrome and BMI Matched Controls. Research in Endocrinology, 2013(), e1-6. https://doi.org/10.5171/2013.503467
- 游雅言（2020）。Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis〔博士論文，中山醫學大學〕。華藝線上圖書館。https://doi.org/10.6834/csmu202000175
- 王智慧（2022）。Metabolic Syndrome and Lowered Hemoglobin Concentrations: A Bidirectional Relationship and the Association of All-cause Mortality Study〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU202203383